Association of body mass index with new-onset atrial fibrillation after coronary artery bypass grafting operations

Annals of Thoracic Surgery

Volumn 91, Issue 6, 2011, Pages 1852-1858

  Sun, Xiumei ^a   Boyce, Steven W ^a   Hill, Peter C ^a   Bafi, Ammar S ^a   Xue, Zhengyi ^a   Lindsay, Joseph ^a   Corso, Paul J ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBESITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL RISK;

ADULT; AGE FACTORS; AGED; ATRIAL FIBRILLATION; BODY MASS INDEX; CORONARY ARTERY BYPASS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE COMPLICATIONS; SLEEP APNEA, OBSTRUCTIVE;

EID: 79957722573     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.03.022     Document Type: Article

References (17)

1. Echahidi N, Pibarot P, O'Hara G, et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793-801. (Pubitemid 351255619)
2. Mayson SE, Greespon AJ, Adams S, et al. The changing face of postoperative atrial fibrillation prevention: A review of current medical therapy. Cardiol Rev 2007;15:231-41. (Pubitemid 47282032)
3. Zacharias A, Schwann TA, Riordan CJ, et al. Obesity and risk of new-onset atrial fibrillation after coronary bypass surgery. Circulation 2005;112:3247-55. (Pubitemid 43739369)
4. Echahidi N, Mohty D, Pibarot P, et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation 2007; 116:I-213-9.
5. Wanahita N, Messerli FH, Bangalore S, et al. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008;155:310-5.
6. Gami AS, Hodge DO, Herdges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;749:565-71. (Pubitemid 46177437)
7. Wang TJ, Parise H, Levy V, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7. (Pubitemid 39552671)
8. Centers for Disease Control and Prevention. National Center for Health Statistics. www.cdc.gov/NCHS.
9. Palmer KT, Cullinan P, Rice S, Brown T, Coggon D. Mortality for infectious pneumonia in metal workers: a comparison with deaths from asthma in occupations exposed to respiratory sensitisers. Thorax 2009;64:983-86.
10. Gami AS, Pressman GP, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004;110:364-7. (Pubitemid 38993843)
11. Mooe T, Gullsby S, Rabben T, et al. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 1996;7:475-8. (Pubitemid 26330652)
12. Kowey PR, Stebbings D, Igidbashian L, et al. Clinical outcomes of patients who develop PAF after CABG surgery. Pacing Clin Electrophysiol 2001;24:191-3. (Pubitemid 32207591)
13. Pritchett AM, Jacobsen SJ, Mahoney DW, et al. Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol 2003;41:1036-43. (Pubitemid 36315550)
14. Pi-Sunyer FX. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002;10 (suppl 2):1472-76.
15. European Heart Rhythm Association, Heart Rhythm Society, Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the management of Patients with Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906.
16. Ducharme A, Swedberg K, Pfeffer MA, et al. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Am Heart J 2006;152:86-92.
17. Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-9. (Pubitemid 40789940)